Nov 6
|
Controversial brand back, survives Chapter 11 bankruptcy
|
Nov 6
|
J&J links radiofrequency catheter to improved quality of life in atrial fibrillation study
|
Nov 4
|
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever
|
Nov 3
|
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
|
Nov 3
|
3 Healthcare Stocks to Buy Hand Over Fist in November
|
Nov 2
|
Johnson & Johnson's Long-Term Charts Got a Boo-boo
|
Nov 2
|
Smith+Nephew plays down concerns about weight-loss drugs
|
Nov 1
|
Chart of the Day: Is This Bullpen Name Ready for a Call-Up?
|
Oct 29
|
14 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds
|
Oct 29
|
'Things were way tougher': Charlie Munger shares blunt message with whiners worrying about 'hardship' — plus 3 stocks Warren Buffett's right-hand man uses to supercharge his finances
|
Oct 28
|
Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime
|
Oct 28
|
Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now
|
Oct 27
|
UPDATE 1-J&J says DoJ seeking information related to eye products in civil investigation
|
Oct 27
|
AbbVie (ABBV) Q3 Earnings Beat, Shares Down Despite Raised View
|
Oct 26
|
2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive Income
|
Oct 26
|
3 Pharma Stocks That Are Screaming Buys in October
|
Oct 26
|
UPDATE 2-Kenvue cuts annual profit forecast on soft demand for cold, flu medicines
|
Oct 25
|
2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?
|
Oct 24
|
Dividend Capture Strategy: 10 High Yield Stocks To Buy in November
|
Oct 24
|
Johnson & Johnson Stock Skirts a 52-Week Low. Here’s What’s Ailing Healthcare.
|